The question of whether progesterone should be considered if one does not have a uterus is indeed complex and warrants careful consideration. Progesterone is primarily known for its role in preparing the uterine lining for pregnancy and regulating the menstrual cycle. For individuals with a uterus, especially those undergoing hormone replacement therapy (HRT) during menopause, progesterone is essential because it counteracts the proliferative effects of estrogen on the uterine lining, reducing the risk of endometrial hyperplasia and cancer.

However, in the absence of a uterus, such as after a hysterectomy, the primary reason for progesterone supplementation-to protect the uterus-is no longer applicable. Many healthcare providers may therefore prescribe estrogen-only HRT to individuals without a uterus, as the risk of endometrial hyperplasia does not exist. This approach often simplifies hormone management and reduces exposure to unnecessary hormones.

That said, progesterone may still have other systemic effects beyond the uterus, including roles in bone health, brain function, mood regulation, and cardiovascular health. Some studies suggest neuroprotective and anxiolytic properties of progesterone, although the clinical benefits of supplementation in these areas without a uterine indication remain less clear and are subject to ongoing research.

Ultimately, the decision to include progesterone should be personalized, based on a comprehensive evaluation of symptoms, overall health, and treatment goals. Consulting with a knowledgeable healthcare professional who understands the nuanced roles of hormones and can tailor HRT accordingly is crucial. While progesterone may not be necessary solely for uterine protection when the uterus is absent, potential benefits in other domains might justify its use in certain cases.